Soltis Investment Advisors’s Boston Scientific BSX Stock Holding History

Soltis Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Sell	6,292 -584	-8%	-$31.7K	0.01%	535
2026 Q1	$431K	Buy	6,876 +2,056	+43%	+$164K	0.03%	372
2025 Q4	$460K	Buy	4,820 +218	+5%	+$21.4K	0.03%	337
2025 Q3	$449K	Buy	4,602 +717	+18%	+$74.3K	0.03%	315
2025 Q2	$417K	Buy	3,885 +381	+11%	+$38.5K	0.03%	275
2025 Q1	$353K	Buy	3,504 +498	+17%	+$50.1K	0.03%	278
2024 Q4	$268K	Buy	3,006 +146	+5%	+$12.9K	0.02%	308
2024 Q3	$240K	Buy	+2,860	New	+$225K	0.02%	317

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Soltis Investment Advisors's BSX Position: Q2 2026 in Review

Soltis Investment Advisors reduced its Boston Scientific (BSX) stake by 8.5% in Q2 2026, selling an estimated $31.7K and leaving 6,292 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #535.

Soltis Investment Advisors first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $460K in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Soltis Investment Advisors held 6,292 shares of Boston Scientific worth $269K as of Q2 2026.
Soltis Investment Advisors sold 584 Boston Scientific shares in Q2 2026, an estimated $31.7K.
Boston Scientific made up 0.01% of Soltis Investment Advisors's portfolio in Q2 2026, its #535 holding.
Soltis Investment Advisors first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
Soltis Investment Advisors's Boston Scientific position peaked at $460K in Q4 2025.
770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.